HeartCore Enterprises, Inc. — Form 8-K Summary
Business Context and Reporting Period
The Form 8-K was filed on April 6, 2022, reporting events beginning March 31, 2022. HeartCore Enterprises, Inc. is a Delaware corporation headquartered in Tokyo, Japan, with common stock traded on the Nasdaq Capital Market under the symbol HTCR. The company reported entering a material consulting agreement and launching its “Go IPO” consulting service for Japanese companies seeking potential U.S. exchange listings.
Material Agreement and Financial Terms
- On March 31, 2022, HeartCore entered into a Consulting and Services Agreement with Moveaction Co., Ltd.
- Services include IPO preparation support, assistance with selecting professional advisers, process-mining and task-mining licenses, internal-control documentation, Japanese-to-U.S. GAAP conversion, translation, listing support, website development, and preparation of investor materials.
- Moveaction agreed to pay $460,000 during the initial nine-month term: $180,000 on the effective date, $140,000 after three months, and $140,000 after six months.
- During renewal terms, compensation will be $150 per hour. The agreement automatically renews for additional nine-month periods unless terminated with at least 30 days’ prior notice.
- Moveaction also issued HeartCore a warrant to purchase eight shares of Moveaction common stock at $0.01 per share. The warrant becomes exercisable after Moveaction completes a qualifying U.S. IPO and remains exercisable through the tenth anniversary of the IPO date, subject to adjustment provisions and a 9.99% equity blocker.
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity
This Form 8-K does not provide financial statements or clear information regarding revenue recognition, profit, cash flow, margins, debt, cash balances, liquidity, or other company-wide financial metrics. The disclosed $460,000 represents contractual consideration under the Moveaction agreement and should not be assumed to equal recognized revenue or cash received during the reporting period.
Changes Versus the Prior Comparable Period
The filing does not present comparative financial results or quantify changes from a prior comparable period. The material developments are the new Moveaction consulting agreement, issuance of the warrant, and launch of the Go IPO service.
Guidance, Outlook, Risks, and Unusual Items
- HeartCore stated that it cannot guarantee that a client will successfully complete an IPO, satisfy Nasdaq listing standards, or obtain approval of a listing application.
- The company will not provide accounting services or act as an investment adviser or broker-dealer.
- Excluded activities include negotiating securities sales, participating in potential-investor discussions, structuring securities transactions, pre-screening investors, performing due diligence, and advising on investment valuation or financial advisability.
- The warrant’s value and liquidity depend on Moveaction completing a qualifying U.S. IPO and other conditions; the filing does not provide a fair value or accounting treatment for the warrant.
- The Go IPO announcement was furnished under Regulation FD and is not deemed filed for purposes of Section 18 of the Exchange Act or incorporated by reference, except where expressly stated.
Key Facts Investors Should Verify
- Whether and when the $460,000 contractual payments were received and recognized as revenue.
- The accounting treatment, valuation, and any restrictions associated with the Moveaction warrant.
- Whether Moveaction ultimately completed a qualifying IPO and whether the warrant became exercisable.
- The number of active Go IPO engagements, related pipeline, expected timing, and associated costs.
- Any subsequent filings disclosing termination, renewal, modification, or performance issues under the consulting agreement.
- Current cash, debt, liquidity, and operating results, which are not provided in this filing.